MARISOL BARAJAS: Open Payments
NPI 1396443222 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 23 payments from 8 companies in 2025. Trend: 2023 $197 · 2024 $154 · 2025 $517
Food & beverage: $517
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $166 |
| GENZYME CORPORATION | 5 | $140 |
| ABBVIE INC. | 4 | $84 |
| Janssen Biotech, Inc. | 2 | $50 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| QOL Medical, LLC | 1 | $14 |
Products named: DUPIXENT, TREMFYA, RINVOQ, VOQUEZNA, LINZESS, CREON, ZENPEP, ENTYVIO.
Industry payments across LA — which companies pay providers there.
